Clinical and translational research plays a vital role in determining treatment plans at Houston Methodist and in bringing tomorrow's cures to our patients today. Explore the bridges between research and clinical care that have been built by our interdisciplinary faculty team and global network of collaborators.
COMBINING PAP AND HRHPV TESTS TO REDUCE CANCER MISS RATES
Houston Methodist study shows that co-testing with PAP and hrHPV would miss significantly fewer cervical cancers than either test performed alone. Learn More.
INJECTABLE NANOPARTICLE GENERATOR FOR METASTATIC BREAST CANCER TREATMENT
Researchers from the Houston Methodist Research Institute have developed the first drug delivery system to successfully eliminate lung metastases in mice models with triple negative breast cancer. Learn more.
Nanoconstructs for Cancer Theranostics AND Targeted Delivery
Researchers have developed specialized nanoconstructs for targeted systemic delivery of imaging agents and therapeutic agents to cancer cells in the body. Learn More.